Structure

Physi-Chem Properties

Molecular Weight:  562.16
Volume:  561.58
LogP:  6.533
LogD:  3.714
LogS:  -2.748
# Rotatable Bonds:  2
TPSA:  132.75
# H-Bond Aceptor:  8
# H-Bond Donor:  5
# Rings:  8
# Heavy Atoms:  8

MedChem Properties

QED Drug-Likeness Score:  0.144
Synthetic Accessibility Score:  4.542
Fsp3:  0.176
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.335
MDCK Permeability:  1.03183865576284e-05
Pgp-inhibitor:  0.121
Pgp-substrate:  0.372
Human Intestinal Absorption (HIA):  0.577
20% Bioavailability (F20%):  0.999
30% Bioavailability (F30%):  1.0

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.0
Plasma Protein Binding (PPB):  94.58140563964844%
Volume Distribution (VD):  0.696
Pgp-substrate:  2.5469918251037598%

ADMET: Metabolism

CYP1A2-inhibitor:  0.541
CYP1A2-substrate:  0.376
CYP2C19-inhibitor:  0.96
CYP2C19-substrate:  0.056
CYP2C9-inhibitor:  0.906
CYP2C9-substrate:  0.979
CYP2D6-inhibitor:  0.791
CYP2D6-substrate:  0.658
CYP3A4-inhibitor:  0.779
CYP3A4-substrate:  0.307

ADMET: Excretion

Clearance (CL):  7.516
Half-life (T1/2):  0.27

ADMET: Toxicity

hERG Blockers:  0.158
Human Hepatotoxicity (H-HT):  0.264
Drug-inuced Liver Injury (DILI):  0.946
AMES Toxicity:  0.492
Rat Oral Acute Toxicity:  0.85
Maximum Recommended Daily Dose:  0.98
Skin Sensitization:  0.948
Carcinogencity:  0.893
Eye Corrosion:  0.003
Eye Irritation:  0.879
Respiratory Toxicity:  0.866

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC59491

Natural Product ID:  NPC59491
Common Name*:   Albanol A
IUPAC Name:   n.a.
Synonyms:  
Standard InCHIKey:  MJJWBJFYYRAYKU-WLKQUGLZSA-N
Standard InCHI:  InChI=1S/C34H26O8/c1-16-8-23-22-6-4-21(37)15-30(22)41-34(25-7-5-19(35)13-26(25)38)33(23)24(9-16)32-27(39)10-18(12-31(32)42-34)28-11-17-2-3-20(36)14-29(17)40-28/h2-7,9-15,23-24,33,35-39H,8H2,1H3/t23-,24-,33?,34+/m1/s1
SMILES:  CC1=C[C@@H]2c3c(cc(cc3O[C@@]3(c4ccc(cc4O)O)C2[C@H](C1)c1ccc(cc1O3)O)c1cc2ccc(cc2o1)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL454705
PubChem CID:   44567218
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0003405] 2-arylbenzofuran flavonoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO5495 Broussonetia papyrifera Species Moraceae Eukaryota n.a. root n.a. PMID[11395279]
NPO5495 Broussonetia papyrifera Species Moraceae Eukaryota whole plants Shawnee National Forest, Harrisburg, IL, US n.a. PMID[11678652]
NPO5495 Broussonetia papyrifera Species Moraceae Eukaryota whole plants n.a. n.a. PMID[11678652]
NPO5495 Broussonetia papyrifera Species Moraceae Eukaryota n.a. n.a. n.a. PMID[12419367]
NPO5495 Broussonetia papyrifera Species Moraceae Eukaryota leaves Kaohsiung, Taiwan 2006-SEP PMID[18986201]
NPO5495 Broussonetia papyrifera Species Moraceae Eukaryota Fruits n.a. n.a. PMID[19296617]
NPO28265 Morus alba Species Moraceae Eukaryota n.a. n.a. n.a. PMID[20815207]
NPO28265 Morus alba Species Moraceae Eukaryota n.a. bark n.a. PMID[21319773]
NPO28265 Morus alba Species Moraceae Eukaryota n.a. root n.a. PMID[21319773]
NPO28265 Morus alba Species Moraceae Eukaryota n.a. leaf n.a. PMID[21319773]
NPO28265 Morus alba Species Moraceae Eukaryota n.a. leaf n.a. PMID[22207282]
NPO28265 Morus alba Species Moraceae Eukaryota n.a. root n.a. PMID[23806866]
NPO28265 Morus alba Species Moraceae Eukaryota root bark University of Veterinary and Pharmaceutical Sciences Brno (UVPS Brno), Brno, Czech Republic 2011-APR PMID[24901948]
NPO28265 Morus alba Species Moraceae Eukaryota n.a. Konya, Turkey 2007-APR PMID[24901948]
NPO28265 Morus alba Species Moraceae Eukaryota leaves Chungbuk, Korea n.a. PMID[25935644]
NPO28265 Morus alba Species Moraceae Eukaryota n.a. root n.a. PMID[25981820]
NPO28265 Morus alba Species Moraceae Eukaryota n.a. latex n.a. PMID[27294120]
NPO28265 Morus alba Species Moraceae Eukaryota Root barks n.a. n.a. PMID[3097265]
NPO5495 Broussonetia papyrifera Species Moraceae Eukaryota n.a. formosan n.a. PMID[8864236]
NPO5495 Broussonetia papyrifera Species Moraceae Eukaryota n.a. n.a. n.a. PMID[9358644]
NPO5495 Broussonetia papyrifera Species Moraceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO28265 Morus alba Species Moraceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO28265 Morus alba Species Moraceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO5495 Broussonetia papyrifera Species Moraceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO28265 Morus alba Species Moraceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO5495 Broussonetia papyrifera Species Moraceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO28265 Morus alba Species Moraceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO5495 Broussonetia papyrifera Species Moraceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO28265 Morus alba Species Moraceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO5495 Broussonetia papyrifera Species Moraceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT441 Individual Protein Cytochrome P450 19A1 Homo sapiens IC50 = 7500.0 nM PMID[552599]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC59491 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC24748
0.9877 High Similarity NPC101991
0.9758 High Similarity NPC121888
0.9627 High Similarity NPC169471
0.9509 High Similarity NPC286230
0.9509 High Similarity NPC253730
0.9444 High Similarity NPC159508
0.9193 High Similarity NPC137100
0.9 High Similarity NPC300657
0.897 High Similarity NPC312273
0.897 High Similarity NPC301256
0.8941 High Similarity NPC73899
0.8941 High Similarity NPC474276
0.8941 High Similarity NPC17105
0.8941 High Similarity NPC147363
0.8922 High Similarity NPC473010
0.8916 High Similarity NPC473012
0.8882 High Similarity NPC167576
0.8869 High Similarity NPC251336
0.8862 High Similarity NPC473009
0.8862 High Similarity NPC38591
0.8848 High Similarity NPC51760
0.8848 High Similarity NPC105584
0.8841 High Similarity NPC56049
0.8841 High Similarity NPC54830
0.8834 High Similarity NPC72370
0.8817 High Similarity NPC292233
0.8802 High Similarity NPC15374
0.8795 High Similarity NPC312993
0.8795 High Similarity NPC195136
0.8788 High Similarity NPC271741
0.8788 High Similarity NPC96342
0.8788 High Similarity NPC212967
0.8788 High Similarity NPC287789
0.8788 High Similarity NPC246647
0.8788 High Similarity NPC164110
0.8765 High Similarity NPC470206
0.8765 High Similarity NPC78335
0.8765 High Similarity NPC470207
0.8765 High Similarity NPC230713
0.875 High Similarity NPC87583
0.8743 High Similarity NPC189552
0.8743 High Similarity NPC273467
0.8736 High Similarity NPC114257
0.8736 High Similarity NPC299149
0.8736 High Similarity NPC153578
0.8736 High Similarity NPC277710
0.8735 High Similarity NPC472877
0.8735 High Similarity NPC177650
0.8727 High Similarity NPC69531
0.8727 High Similarity NPC61112
0.8727 High Similarity NPC198489
0.8727 High Similarity NPC180924
0.8727 High Similarity NPC309648
0.872 High Similarity NPC472462
0.872 High Similarity NPC235333
0.872 High Similarity NPC213608
0.872 High Similarity NPC1477
0.8713 High Similarity NPC477572
0.8713 High Similarity NPC287884
0.8713 High Similarity NPC477571
0.8713 High Similarity NPC477573
0.8713 High Similarity NPC8704
0.8712 High Similarity NPC149085
0.8712 High Similarity NPC170169
0.8712 High Similarity NPC193976
0.8712 High Similarity NPC23668
0.8704 High Similarity NPC178202
0.8698 High Similarity NPC474591
0.869 High Similarity NPC477239
0.869 High Similarity NPC477528
0.869 High Similarity NPC3448
0.869 High Similarity NPC473011
0.8683 High Similarity NPC186325
0.8683 High Similarity NPC472052
0.8683 High Similarity NPC98023
0.8683 High Similarity NPC470342
0.8683 High Similarity NPC226462
0.8683 High Similarity NPC472060
0.8678 High Similarity NPC478000
0.8675 High Similarity NPC268360
0.8675 High Similarity NPC1796
0.8675 High Similarity NPC65504
0.8675 High Similarity NPC475184
0.8667 High Similarity NPC14606
0.8667 High Similarity NPC300668
0.8667 High Similarity NPC100049
0.8667 High Similarity NPC158027
0.8667 High Similarity NPC215203
0.8667 High Similarity NPC297531
0.8667 High Similarity NPC265624
0.8667 High Similarity NPC148938
0.8667 High Similarity NPC159707
0.8667 High Similarity NPC213936
0.8667 High Similarity NPC258474
0.8667 High Similarity NPC201227
0.8667 High Similarity NPC248739
0.8667 High Similarity NPC134171
0.8667 High Similarity NPC121649
0.8667 High Similarity NPC52611
0.8667 High Similarity NPC186227
0.8667 High Similarity NPC150908
0.8667 High Similarity NPC99199
0.8667 High Similarity NPC205026
0.8663 High Similarity NPC477529
0.8659 High Similarity NPC207624
0.8659 High Similarity NPC142308
0.8659 High Similarity NPC5871
0.8655 High Similarity NPC53252
0.8639 High Similarity NPC155640
0.8631 High Similarity NPC18380
0.8631 High Similarity NPC175513
0.8623 High Similarity NPC226287
0.8623 High Similarity NPC55443
0.8623 High Similarity NPC51247
0.8623 High Similarity NPC244750
0.8623 High Similarity NPC15815
0.8623 High Similarity NPC18699
0.8623 High Similarity NPC40583
0.8621 High Similarity NPC475246
0.8614 High Similarity NPC32867
0.8614 High Similarity NPC13879
0.8613 High Similarity NPC168789
0.8606 High Similarity NPC71061
0.8606 High Similarity NPC290830
0.8606 High Similarity NPC72425
0.8606 High Similarity NPC303485
0.8606 High Similarity NPC194593
0.8598 High Similarity NPC138299
0.8598 High Similarity NPC111112
0.8598 High Similarity NPC115324
0.8598 High Similarity NPC222713
0.8598 High Similarity NPC58668
0.8598 High Similarity NPC67322
0.8598 High Similarity NPC106372
0.8596 High Similarity NPC47905
0.8596 High Similarity NPC139683
0.8596 High Similarity NPC73929
0.8589 High Similarity NPC226644
0.8589 High Similarity NPC37226
0.8588 High Similarity NPC154527
0.8588 High Similarity NPC469664
0.858 High Similarity NPC310603
0.858 High Similarity NPC17816
0.858 High Similarity NPC150215
0.8571 High Similarity NPC115432
0.8571 High Similarity NPC184326
0.8571 High Similarity NPC155144
0.8571 High Similarity NPC121647
0.8571 High Similarity NPC260296
0.8571 High Similarity NPC292863
0.8571 High Similarity NPC5671
0.8571 High Similarity NPC42965
0.8563 High Similarity NPC3718
0.8563 High Similarity NPC257166
0.8555 High Similarity NPC478002
0.8555 High Similarity NPC477836
0.8555 High Similarity NPC174700
0.8554 High Similarity NPC198490
0.8554 High Similarity NPC66441
0.8554 High Similarity NPC254351
0.8554 High Similarity NPC226656
0.8554 High Similarity NPC79375
0.8554 High Similarity NPC37253
0.8554 High Similarity NPC182555
0.8554 High Similarity NPC66508
0.8539 High Similarity NPC475220
0.8539 High Similarity NPC221140
0.8539 High Similarity NPC226725
0.8539 High Similarity NPC473686
0.8539 High Similarity NPC229817
0.8539 High Similarity NPC475352
0.8539 High Similarity NPC304322
0.8538 High Similarity NPC477835
0.8538 High Similarity NPC224851
0.8531 High Similarity NPC475662
0.8531 High Similarity NPC473631
0.8531 High Similarity NPC293227
0.8531 High Similarity NPC132111
0.8531 High Similarity NPC473717
0.8528 High Similarity NPC135325
0.8521 High Similarity NPC137232
0.8519 High Similarity NPC210826
0.8514 High Similarity NPC46958
0.8514 High Similarity NPC475233
0.8514 High Similarity NPC472661
0.8512 High Similarity NPC474373
0.8512 High Similarity NPC324736
0.8512 High Similarity NPC295090
0.8512 High Similarity NPC195167
0.8506 High Similarity NPC65885
0.8506 High Similarity NPC85368
0.8506 High Similarity NPC470336
0.8506 High Similarity NPC473834
0.8506 High Similarity NPC470335
0.8497 Intermediate Similarity NPC17884
0.8497 Intermediate Similarity NPC19273
0.8497 Intermediate Similarity NPC476641
0.8494 Intermediate Similarity NPC183874
0.8494 Intermediate Similarity NPC121568

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC59491 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8743 High Similarity NPD6959 Discontinued
0.8563 High Similarity NPD3749 Approved
0.8506 High Similarity NPD6559 Discontinued
0.848 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.8333 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.8232 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.8202 Intermediate Similarity NPD8313 Approved
0.8202 Intermediate Similarity NPD8312 Approved
0.8176 Intermediate Similarity NPD7768 Phase 2
0.8166 Intermediate Similarity NPD7819 Suspended
0.8155 Intermediate Similarity NPD7411 Suspended
0.8129 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.8125 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.8114 Intermediate Similarity NPD7473 Discontinued
0.8079 Intermediate Similarity NPD7074 Phase 3
0.8068 Intermediate Similarity NPD3818 Discontinued
0.8061 Intermediate Similarity NPD7390 Discontinued
0.8057 Intermediate Similarity NPD6166 Phase 2
0.8057 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.8057 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.8046 Intermediate Similarity NPD6232 Discontinued
0.8035 Intermediate Similarity NPD5494 Approved
0.8023 Intermediate Similarity NPD7054 Approved
0.8012 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7978 Intermediate Similarity NPD7472 Approved
0.7978 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7953 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7944 Intermediate Similarity NPD7808 Phase 3
0.7933 Intermediate Similarity NPD6797 Phase 2
0.7933 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7914 Intermediate Similarity NPD2344 Approved
0.7892 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7889 Intermediate Similarity NPD7251 Discontinued
0.7882 Intermediate Similarity NPD4380 Phase 2
0.7866 Intermediate Similarity NPD1549 Phase 2
0.7861 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7824 Intermediate Similarity NPD3226 Approved
0.7821 Intermediate Similarity NPD5844 Phase 1
0.7818 Intermediate Similarity NPD2800 Approved
0.7816 Intermediate Similarity NPD7075 Discontinued
0.7805 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7805 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7798 Intermediate Similarity NPD2533 Approved
0.7798 Intermediate Similarity NPD2534 Approved
0.7798 Intermediate Similarity NPD2532 Approved
0.7791 Intermediate Similarity NPD1934 Approved
0.7778 Intermediate Similarity NPD1607 Approved
0.7771 Intermediate Similarity NPD3750 Approved
0.7759 Intermediate Similarity NPD3882 Suspended
0.7746 Intermediate Similarity NPD2801 Approved
0.7744 Intermediate Similarity NPD8151 Discontinued
0.7738 Intermediate Similarity NPD1511 Approved
0.7725 Intermediate Similarity NPD2309 Approved
0.7711 Intermediate Similarity NPD1243 Approved
0.7706 Intermediate Similarity NPD920 Approved
0.7697 Intermediate Similarity NPD3926 Phase 2
0.7683 Intermediate Similarity NPD1510 Phase 2
0.7665 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7654 Intermediate Similarity NPD1240 Approved
0.765 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7647 Intermediate Similarity NPD1512 Approved
0.7644 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7644 Intermediate Similarity NPD1465 Phase 2
0.7636 Intermediate Similarity NPD2796 Approved
0.7602 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7594 Intermediate Similarity NPD4287 Approved
0.759 Intermediate Similarity NPD2346 Discontinued
0.7588 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7588 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7577 Intermediate Similarity NPD7697 Approved
0.7577 Intermediate Similarity NPD7698 Approved
0.7577 Intermediate Similarity NPD7696 Phase 3
0.7576 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7572 Intermediate Similarity NPD6599 Discontinued
0.7569 Intermediate Similarity NPD3751 Discontinued
0.7545 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7543 Intermediate Similarity NPD8455 Phase 2
0.7538 Intermediate Similarity NPD7871 Phase 2
0.7538 Intermediate Similarity NPD7870 Phase 2
0.753 Intermediate Similarity NPD6100 Approved
0.753 Intermediate Similarity NPD6099 Approved
0.753 Intermediate Similarity NPD5408 Approved
0.753 Intermediate Similarity NPD5405 Approved
0.753 Intermediate Similarity NPD5404 Approved
0.753 Intermediate Similarity NPD5406 Approved
0.7527 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7514 Intermediate Similarity NPD7458 Discontinued
0.7513 Intermediate Similarity NPD6779 Approved
0.7513 Intermediate Similarity NPD6782 Approved
0.7513 Intermediate Similarity NPD6776 Approved
0.7513 Intermediate Similarity NPD6778 Approved
0.7513 Intermediate Similarity NPD6780 Approved
0.7513 Intermediate Similarity NPD6777 Approved
0.7513 Intermediate Similarity NPD6781 Approved
0.75 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD3817 Phase 2
0.7487 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7487 Intermediate Similarity NPD7783 Phase 2
0.7486 Intermediate Similarity NPD6801 Discontinued
0.7473 Intermediate Similarity NPD7228 Approved
0.7471 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.747 Intermediate Similarity NPD3748 Approved
0.747 Intermediate Similarity NPD2799 Discontinued
0.7444 Intermediate Similarity NPD3787 Discontinued
0.7427 Intermediate Similarity NPD6799 Approved
0.7425 Intermediate Similarity NPD2935 Discontinued
0.7425 Intermediate Similarity NPD1551 Phase 2
0.7424 Intermediate Similarity NPD7701 Phase 2
0.7414 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7401 Intermediate Similarity NPD5402 Approved
0.7398 Intermediate Similarity NPD7435 Discontinued
0.7394 Intermediate Similarity NPD8434 Phase 2
0.7389 Intermediate Similarity NPD7199 Phase 2
0.7389 Intermediate Similarity NPD1247 Approved
0.7386 Intermediate Similarity NPD37 Approved
0.7374 Intermediate Similarity NPD6234 Discontinued
0.7374 Intermediate Similarity NPD919 Approved
0.736 Intermediate Similarity NPD4967 Phase 2
0.736 Intermediate Similarity NPD4966 Approved
0.736 Intermediate Similarity NPD4965 Approved
0.7353 Intermediate Similarity NPD7003 Approved
0.7353 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7348 Intermediate Similarity NPD5710 Approved
0.7348 Intermediate Similarity NPD5711 Approved
0.7348 Intermediate Similarity NPD7229 Phase 3
0.732 Intermediate Similarity NPD7699 Phase 2
0.732 Intermediate Similarity NPD7700 Phase 2
0.7317 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7313 Intermediate Similarity NPD7801 Approved
0.7308 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7302 Intermediate Similarity NPD8150 Discontinued
0.7301 Intermediate Similarity NPD4908 Phase 1
0.7284 Intermediate Similarity NPD2798 Approved
0.7283 Intermediate Similarity NPD7893 Clinical (unspecified phase)
0.7278 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.7273 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7273 Intermediate Similarity NPD8320 Phase 1
0.7273 Intermediate Similarity NPD8319 Approved
0.7264 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7264 Intermediate Similarity NPD7874 Approved
0.7259 Intermediate Similarity NPD6823 Phase 2
0.7258 Intermediate Similarity NPD5953 Discontinued
0.7254 Intermediate Similarity NPD6535 Approved
0.7254 Intermediate Similarity NPD6534 Approved
0.7246 Intermediate Similarity NPD6651 Approved
0.7225 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7212 Intermediate Similarity NPD2313 Discontinued
0.7207 Intermediate Similarity NPD2296 Approved
0.72 Intermediate Similarity NPD5403 Approved
0.7189 Intermediate Similarity NPD7177 Discontinued
0.7184 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7176 Intermediate Similarity NPD1471 Phase 3
0.7152 Intermediate Similarity NPD4625 Phase 3
0.7151 Intermediate Similarity NPD7286 Phase 2
0.7151 Intermediate Similarity NPD5760 Phase 2
0.7151 Intermediate Similarity NPD4628 Phase 3
0.7151 Intermediate Similarity NPD5761 Phase 2
0.7128 Intermediate Similarity NPD7240 Approved
0.7126 Intermediate Similarity NPD943 Approved
0.7108 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7108 Intermediate Similarity NPD3764 Approved
0.7099 Intermediate Similarity NPD4749 Approved
0.7086 Intermediate Similarity NPD5401 Approved
0.7045 Intermediate Similarity NPD6273 Approved
0.7037 Intermediate Similarity NPD7685 Pre-registration
0.7026 Intermediate Similarity NPD6212 Phase 3
0.7026 Intermediate Similarity NPD6213 Phase 3
0.7026 Intermediate Similarity NPD6214 Clinical (unspecified phase)
0.7012 Intermediate Similarity NPD1203 Approved
0.7012 Intermediate Similarity NPD1470 Approved
0.7006 Intermediate Similarity NPD3268 Approved
0.7005 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD8155 Clinical (unspecified phase)
0.699 Remote Similarity NPD4360 Phase 2
0.699 Remote Similarity NPD4363 Phase 3
0.6965 Remote Similarity NPD7680 Approved
0.6959 Remote Similarity NPD4308 Phase 3
0.6946 Remote Similarity NPD7584 Approved
0.6933 Remote Similarity NPD1608 Approved
0.6923 Remote Similarity NPD4288 Approved
0.6919 Remote Similarity NPD8366 Approved
0.6909 Remote Similarity NPD2797 Approved
0.6906 Remote Similarity NPD6279 Approved
0.6906 Remote Similarity NPD6280 Approved
0.6905 Remote Similarity NPD6410 Clinical (unspecified phase)
0.6905 Remote Similarity NPD411 Approved
0.6902 Remote Similarity NPD5537 Clinical (unspecified phase)
0.69 Remote Similarity NPD7501 Clinical (unspecified phase)
0.6897 Remote Similarity NPD7211 Clinical (unspecified phase)
0.6886 Remote Similarity NPD6832 Phase 2
0.6882 Remote Similarity NPD447 Suspended
0.6882 Remote Similarity NPD6808 Phase 2
0.6882 Remote Similarity NPD1933 Approved
0.6871 Remote Similarity NPD1201 Approved
0.6871 Remote Similarity NPD1610 Phase 2
0.6869 Remote Similarity NPD4362 Clinical (unspecified phase)
0.6869 Remote Similarity NPD4361 Phase 2
0.6851 Remote Similarity NPD7615 Clinical (unspecified phase)
0.6837 Remote Similarity NPD8059 Phase 3
0.6837 Remote Similarity NPD8058 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data